ArticleThe Journal of clinical investigation2023

ADORA2A-driven proline synthesis triggers epigenetic reprogramming in neuroendocrine prostate and lung cancers.

Na Jing et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.